Comorbidity increases the risk of hospitalizations in MS
Prevention opportunities
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Comorbidity is pervasive throughout health care, affecting the health status of patients, influencing treatment decisions and the resulting outcomes. A recent review of disease multimorbidity patterns showed nonrandom associations for 3 groups: cardiovascular and metabolic diseases, mental health problems, and musculoskeletal disorders.1 Comorbid conditions are frequent in chronic conditions such as multiple sclerosis (MS). In fact, Marrie et al.2 have shown that vascular comorbidities are detectable as early as the time of diagnosis, evidenced by greater self-reported disability in patients with one or more such comorbidities. These authors have also shown that the presence of vascular comorbidities over the course of the disease are associated with a shorter time to impaired ambulation requiring gait assistance of about 6 years.3 Despite the recognized importance of comorbidity, the routine assessment of comorbidities has not been fully appreciated nor implemented in clinical practice.
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 350
- © 2014 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Views & Reviews
COVID-19 Among Patients With Multiple SclerosisA Systematic ReviewMahdi Barzegar, Omid Mirmosayyeb, Mahsa Gajarzadeh et al.Neurology: Neuroimmunology & Neuroinflammation, May 20, 2021 -
Article
Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosisTingting Zhang, Helen Tremlett, Stella Leung et al.Neurology, March 04, 2016 -
Article
Effects of physical comorbidities on disability progression in multiple sclerosisTingting Zhang, Helen Tremlett, Feng Zhu et al.Neurology, January 03, 2018 -
Views & Reviews
The challenge of comorbidity in clinical trials for multiple sclerosisRuth Ann Marrie, Aaron Miller, Maria Pia Sormani et al.Neurology, February 17, 2016